SOURCE: USDM Life Sciences
SANTA BARBARA, CA--(Marketwired - Jan 29, 2014) - USDM Life Sciences, a leading global regulatory consulting firm in the life sciences industry, is pleased to announce Jay Crowley, Vice President of USDM Life Sciences Unique Device Identification practice, will discuss UDI regulations at Oracle Value Chain Summit Wednesday, February 5th at 4 p.m.
"I'm looking forward to discussing how medical device companies should move forward with UDI compliance and help them utilize the benefits of UDI," said Crowley. "USDM is uniquely positioned to help medical device companies become UDI compliant because of our well-established relationships with the most prominent IT vendors in the world."
As Vice President of the UDI practice at USDM Life Sciences, Crowley helps medical device manufacturers achieve regulatory compliance as well as internal benefits and competitive advantage around UDI implementation.
Crowley held various positions over his nearly 27 years at FDA. Most recently, he was Senior Advisor for Patient Safety, in FDA's Center for Devices and Radiological Health. Crowley had primary responsibility for the development and implementation of FDA's Unique Device Identification System.
The USDM Life Sciences Unique Device Identification team will also showcase their UDI regulation guidance and implementation services as well as their Validation Accelerator Packs (VAP's). The USDM Life Sciences VAP's can decrease both validation time and costs by up to 50% and can provide for faster implementation time and better system performance. USDM Life Sciences UDI experts will be at the San Jose McEnery Convention Center, Hall One, Booth #302 February 3-5.
USDM Life Sciences is an Oracle Platinum Partner and Oracle's preferred compliance partner for the life sciences industry. The company provides compliance services for Oracle EBS, JDE, Agile, Taleo Learn, WebCenter, Oracle Cloud Solutions as well as Oracle Clinical and Safety products.
About USDM Life Sciences:
USDM Life Sciences is a leading global regulatory consulting firm providing compliance, validation, qualification, quality, auditing and information technology services via project teams and staff augmentation to our clients in the medical device, biotechnology, biologics, diagnostics and pharmaceutical industries. USDM Life Sciences has more than 13 years of experience supplying our clients in the life science industry with compliance services during each phase of their drug and product development cycle while partnering with best of breed organizations to help companies simplify, unify and optimize their business and compliance objectives. For more information, please visit www.usdm.com.